RSS Alerts

Events & Training for November 2017

LabInnovations 2017

01 November 2017 - 02 November 2017

Lab Innovations 2017 – the UK’s only dedicated showcase for laboratory technology, analytical and biotech equipment – is pleased to welcome Scientific Laboratory Supplies (SLS), Eppendorf and GS Biotech to the NEC, Birmingham, on the 1st and 2nd of November. The UK’s largest independent supplier of scientific products, SLS, is returning for its third consecutive year, as Josh Chapman, marketing director, explained: “Exhibiting at Lab Innovations is a great opportunity to meet with our customers and procurement partners from a variety of industries, and engage with members of our network of over 1,500 suppliers. We launched our new life science catalogue last year, which has proved very successful thanks to the exposure we received at Lab Innovations, and we continue to appreciate this event’s growing prominence in the scientific calendar.”

The NEC, Birmingham, UK

High-Content Analysis and Phenotypic Screening

06 November 2017 - 08 November 2017

The High-Content Analysis and Phenotypic Screening conferences, spanning November 6-8 in Cambridge, MA, bring together academic and pharmaceutical leaders for three days of discussion, networking and learning. The 2017 program focuses on image and data analysis solutions, computational strategies, and assay development for high-content analysis and phenotypic screening. Screening strategies for 3D models and the use of physiologically relevant models for screening, including models in infectious disease, inflammation, neurodegeneration and cancer, will also be discussed.

Boston Marriott, Cambridge, MA, USA

9th Annual PEGS Europe

13 November 2017 - 17 November 2017

PEGS Europe is the largest European event covering all aspects of protein and antibody engineering. In 2016, for the fifth year in a row, a record number of delegates participated in PEGS Europe, as more than 800 attendees from 36 countries convened in beautiful Lisbon, Portugal to discuss the latest advances in protein and antibody engineering. The 2017 event will feature: 800+ attendees 200 technical presentations 140+ scientific posters Dedicated networking opportunities Exclusive exhibit & poster viewing hours Interactive roundtable, breakout & panel discussions

EPIC SANA Lisboa Hotel, Lisbon, Portugal

Pharmaceutical Microbiology East Coast

13 November 2017 - 14 November 2017

Drawing on from the huge success of SMi’s Pharmaceutical Microbiology event series, SMi is delighted to announce the launch of Pharmaceutical Microbiology East Coast. Being the eighth in its series, this event will take place in New Jersey, USA, on November 13th and 14th 2017. Aimed at Microbiologists, Quality Control and Quality Assurance Managers, Pharmaceutical Microbiology East Coast 2017 will address the best practices for rapid microbial and sterility testing and tackle the challenges of contamination control. Pharmaceutical Microbiology East Coast has been produced with a vision of promoting the field of microbiology, and has been tailored to address the current issues and opportunities the industry faces every day. Topics of interest will include: • The role of microbiology in pharmaceutical stability programs • Deciphering the host-microbe interaction • Benefits of real-time monitoring of airborne viable microorganisms • Current expectations for a complete environmental monitoring program • Quality control strategy on low endotoxin recovery (LER) • Implementation of a global electronic intervention logging system

Renaissance Woodbridge Hotel, Iselyn, NJ, USA

Cleanroom Management Summit 2017

15 November 2017 - 16 November 2017

ACI’s Inaugural Cleanroom Management Summit 2017 will be taking place in London, UK, on 15th — 16th of November 2017. The two day event will bring together key industry personnel from the cleanrooms, pharmaceutical manufacturing and microbiological industries. The two day event will put together cleanrooms operators, technicians, quality assurance managers, contamination control and sterile manufacturing experts together for a fantastic, informative and ground breaking conference. The conference will discuss regulations and compliance, information in validation and standards. It will highlight cleanroom’s energy consumption and how to make your cleanrooms more efficient. Conference will also focus on sterile manufacturing and what is required to successfully manufacture sterile products. Other highlights are cleanroom management and all the aspects of effective cleanrooms management to minimise infection and contamination and maximise efficiency, as well as information on gowning and correct cleanroom’s attire and relevant system management techniques. Why Cleanroom Management Summit 2017 is a Must-Attend Cleanrooms Conference: Highlights relevant information on regulation and standards Reviews of latest updates to standards and requirements for a better understanding Gives an insight into effective cleanroom’s management and what is required for good practise Focuses on cleanroom energy consumption and how to minimise usage and maximise performance Overviews contamination control and how to effectively control your cleanrooms to industry standards Investigates sterile manufacturing and the processes used to successfully manufacture products and to maintain the cleanrooms for sterile manufacturing Join us for 2 days of interactive sessions at Cleanroom Management Summit 2017 set on the 15th & 16th of November in London, UK which will serves as a platform for the region’s greatest cleanrooms experts to exchange insights to drive cleanrooms management performance in ways like never before. Register today to visit the conference in London to exchange your point of view with your peers, tackle the challenges & opportunities faced by the cleanrooms and controlled facilities sector together with our expert speakers and engage in excellent networking opportunities.

tbc London, UK

4th Annual Biosimilars North America

15 November 2017 - 16 November 2017

Building on the success of previous events, SMi proudly announces the return of its 4th annual Biosimilars North America Conference, taking place on November 15 and 16, 2017 in Iselin, New Jersey. The market for biosimilars in North America continues to grow and has become highly lucrative. As such, pharmaceutical companies continue to find ways to differentiate their products in such a saturated market. Thus, Biosimilars North America 2017 will provide an intelligent meeting to explore novel and innovative strategies to advance biosimilar development, and ensure optimal market access and commercialization opportunities whilst complying with evolving regulatory requirements. Key highlights this year will include • A presentation from Sandoz on the FDA issuing the long-awaited biosimilar interchangeability guidance • A session on complex biosimilars and new technologies from MedImmune • Momenta Pharmaceuticals will provide strategies to combat legal, policy and commercial obstacles to development and launch • Insights on latest development strategies and market access from Fujifilm Diosynth Biotechnologies • A talk on drug product and formulation development considerations with Oncobiologics Key speakers include • Richard DiCicco, Chairman, Harvest Moon Pharmaceuticals Inc • Cindy Cao, Executive Director & Head of US Regulatory Affairs for Biopharmaceuticals, Sandoz • T. Shantha Raju, Senior Director, MedImmune • Chrys Kokino, Head Global Biologics Commercial, Mylan • Steinar Madsen, Medical Director, Norwegian Medicines Agency • Bruce Leicher, Senior Vice President and General Counsel, Momenta Pharmaceuticals, Inc • Hiten Gutka, Principal Scientist Formulation Development - Biosimilar Development, Oncobiologics Inc • Patrick Robertson, Director, Program Design, FUJIFIlM Diosynth Biotechnologies

Renaissance Woodbridge Hotel, Iselyn, NJ, USA

2nd Annual Mastering Medicinal Chemistry event

15 November 2017 - 17 November 2017

Cambridge Healthtech Institute’s Mastering Medicinal Chemistry conference, which is entering its 15th year in the U.S. is now establishing itself in Europe. Once again, this event will bring together drug discovery scientists from pharma/biotech companies and academia to talk about new technologies, open innovation, collaboration, and insightful case studies. Panel discussions, poster presentations, and interactive breakout discussions, will provide opportunity for active networking and brainstorming with experts in the field. This event will cover topics that are very important and relevant to medicinal chemists that include hit-to-lead identification and validation, lead optimization, designing safer drugs, working with new targets and drug modalities, evaluating new technologies for drug synthesis and screening and more.

Sheraton Lisboa Hotel and Spa, Lisbon, Portugal

Lyophilization USA

16 November 2017 - 17 November 2017

About Lyophilization USA Following its successful second year, SMi Group announces the return of its 3rd annual Lyophilization USA Conference to New Jersey, this November 2017. As biopharmaceuticals continue to dominate the market, the need for greater shelf life and protein stability, has increased. For many biological products lyophilization is a necessity and the technology is constantly advancing. One of the main challenges in pharmaceutical lyophilization, continues to be the scale - up and the implementation of QbD protocols for the optimization of cycles. Several companies are researching and developing ways to facilitate commercial bulk lyophilization of vaccines, protein and cells while also reducing costs. Lyophilization USA will gather leading experts from top pharma companies to discuss the latest cutting edge developments in freeze drying, as well as solutions to on-going industry challenges. Key Topics Addressed: - The impact of controlled nucleation on product quality and the technology being used for controlled ice nucleation. - Examining the development and scale up of a freeze-drying cycle for biotherapeutics. - Highlighting the approaches to effective holistic packaging and innovative design.

Renaissance Woodbridge Hotel, Iselyn, NJ, USA

Novel Therapies for Cancer and Emerging Targets

16 November 2017 - 17 November 2017

Understanding tumour heterogeneity and targeting specific cell populations will impact the growth of the disease. At the 2nd Annual Novel Therapies for Cancer and Emerging Targets conference, during the Improvements in Targeting Cancer session, several researchers will describe their unique approaches to: • Targeting specific cell populations with proteomic technologies • Selectively engaging T-cells at tumor sites • Improving CAR T cell function by reversing the immunosuppressive tumor environment • Overcoming resistance against EGFR monotherapy with tetravalent bispecific antibodies

EPIC SANA Lisboa Hotel, Lisbon, Portugal

Superbugs & Superdrugs USA

27 November 2017 - 28 November 2017

Building on almost two decades worth of expertise in fighting the growing threat of antimicrobial resistance (AMR), SMi Group are thrilled to announce the return of Superbugs and Superdrugs USA which arrives to Iselin, New Jersey on November 13th & 14th 2017. Antimicrobial resistance has sparked an urgency in the development of new drugs as the industry strives for novel solutions to fight infectious diseases. Innovation and collaboration is requested at every level making Superbugs & Superdrugs USA, the perfect platform to strengthen knowledge in key principles such as funding incentives and global strategy, whilst honing in on clinical developments in areas such as immunotherapy, toxoid based vaccines and anti-body drug conjugates. As methods move away from traditional small molecule antibiotics, this is critical time for AMR experts, government bodies and industry leaders, to come together and share ideas on the latest developments in treatment and prevention. Featured speakers include: Janssen, UNT Health Science Center, John Rex from CARB-X, BARDA, Pfizer, Merck, DemovaMed, Visterrra, Microbiotix more.

Renaissance Woodbridge Hotel, Iselin, NJ USA

Ophthalmic Drugs

28 November 2017 - 29 November 2017

Ocular disease therapy has seen a surge in innovation in areas ranging from glaucoma to macular degeneration and diabetic retinopathy. As ageing populations grow globally the need for treatment in this field has grown and is expected to reach a figure of $21 billion by the year 2022. Ophthalmic Drugs will gather industry leaders to discuss the latest challenges and changes in the field of ophthalmology. Explore novel approaches to treatment, ocular medical devices, targeted drug delivery technology and real-life challenges to pre-clinical and clinical trials, to deepen your understanding of inherited ocular diseases.

Copthorne Tara Hotel, Scarsdale Place, Kensington, London, UK

Copyright © 2024
Elsevier Ltd. All rights reserved.
Sitemap | Terms & Conditions | Privacy | | Website Design Working with water